Harlow, United Kingdom

Jamie Knight

This inventor holds 3 USPTO granted patents and 3 EPO patents. Top assignee: Genentech, Inc.. Active years: 2018-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jamie Knight. Retrieved from https://idiyas.com/inventor/jamie-knight-162sx203

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 66.7

 

Average Co-Inventor Count = 10.6

ph-index = 1

Forward Citations = 6(Granted Patents)


Location History:

  • Harlow, GB (2018)
  • Harlow Essex, GB (2019)

Company Filing History:


Years Active: 2018-2019

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: Jamie Knight: Innovator in Pharmaceutical Chemistry

Introduction

Jamie Knight is a notable inventor based in Harlow, GB, recognized for his contributions to pharmaceutical chemistry. With a total of three patents to his name, he has made significant strides in the field of drug development.

Latest Patents

Among his latest innovations are the tricyclic PI3K inhibitor compounds and methods of use. These compounds exhibit phosphoinositide-3 kinase (PI3K) modulation activity, showcasing a promising approach to therapeutic applications.

Career Highlights

Jamie has worked with prestigious companies such as Genentech, Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has allowed him to refine his expertise and contribute to groundbreaking research.

Collaborations

Throughout his career, Jamie has collaborated with talented individuals, including Emily J. Hanan and Hans Purkey. These partnerships have fostered an environment of innovation and creativity in his work.

Conclusion

In summary, Jamie Knight is a distinguished inventor whose work in pharmaceutical chemistry continues to impact the industry positively. His patents and collaborations reflect his commitment to advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…